Lymphoma Research Foundation gives grants for follicular, mantle cell lymphomas

The Lymphoma Research Foundation (www.lymphoma.org) has just added to its ever-growing and influential research portfolio by awarding in excess of $2 million in grants to the following researchers and research groups investigating various areas of lymphoma:

Follicular Lymphoma

John (Wing) Chan, MD,
Board of Regents of the University of Nebraska Medical Center
Oncogenic mutations in follicular and transformed follicular lymphoma

Laurence Cooper, MD
University of Texas M.D. Anderson Cancer Center
Off-The-Shelf Immunotherapy For Follicular Lymphoma Infusing CD19-Specific T Cells

David Frank, MD, PhD
Dana-Farber Cancer Institute
Identification and Targeting of Transcription Factor Pathways Activated in Follicular Lymphoma

Mantle Cell Lymphoma:

Elias Campo, MD
Institute for Biomedical Research August Pi i Sunyer (Barcelona, Spain)
Identification of Somatic Mutations in Mantle Cell Lymphoma Using Next Generation Sequencing

Samuel Katz, MD, PhD
Dana-Farber Cancer Institute
Reactivating Apoptosis in Mantle Cell Lymphoma by Peptide Replacement of the Tumor Suppressor BIM

Izidore Lossos, MD
Miller School of Medicine of the University of Miami
New Immunotherapeutic Approaches to Mantle Cell Lymphoma

Thomas Tedder, PhD
Duke University Medical Center
Molecular Insights into MCL Immunotherapy

“These grants emphasize the Foundation’s commitment to ensuring that the brightest research minds are able to pursue a cure for each of the specific types of lymphoma,” said Diane Blum, CEO of the Lymphoma Research Foundation. “We remain grateful for our supporters, whose continued confidence in our organization and the LRF mission sustains this important work.”

More Articles

More Articles

This entry looks at what is sometimes referred to as mesenteric lymphoma, also referred to as non-Hodgkin's...

In T cell lymphoma, T lymphocytes, which are an essential part of the body's immune response, become malignant. T cell lymphomas account for about...

Lymphoma is a cancer affecting the white blood cells (lymphocytes) of the body's immune system. The cells begin to grow abnormally and much faster...

RICE is an acronym for an anti-cancer treatment that expresses a combination chemotherapeutic regimen. This regimen is written variously as "R+ICE...

B cell lymphoma is not one disease but a few dozen heterogeneous diseases, or individual cancers, that affect the b...

Mantle cell lymphoma (MCL) is just one of 50-60 known B-cell subtypes of...

What causes lymphoma is not well known. DNA mutations may be what causes lymphoma to develop but what triggers these mutations is...

A B cell is a type of lymphocyte that produces antibodies to fight infections. These are the most prevalent lymphocytes in the bloodstream and are...

Also known as Hodgkin's disease, Hodgkin's lymphoma (HL) is a cancer of the white blood cells, or...

Canine lymphoma, just like lymphoma in humans, can be separated into stages,...

This article looks at the Non-Hodgkin's Lymphoma survival rate as well as the Non-Hodgkin's Lymphoma mortality rate ....

T-Cell Lymphoblastic Lymphoma (T-LBL) is a very rare subtype of non-Hodgkin's lymphoma. It tends to develop in...

It's not uncommon for patients with some lymphomas to experience itching (clinically known as pruritus). Lymphoma itching symptoms can range from...

In non-Hodgkin's lymphoma, you have your B-cell lymphomas and you have your T-cell lymphomas.

Why B...